Table 1

Clinical characteristics of study population (>1000 g) in pre-implementation and post-implementation period (pre: n=216 030 births; n=5043 perinatal deaths; post: 111 526 births; n=2486 perinatal deaths)

CharacteristicPre-implementation periodPost-implementation period
Live births, n (%)Perinatal deaths, n (%)Live births, n (%)Perinatal deaths, n (%)
Pregnancy
 Single pregnancy213 222 (98.7)3636 (72.1)110 076 (98.7)1738 (69.9)
 Multiple pregnancy2808 (1.3)237 (4.7)1450 (1.3)142 (5.7)
 Unknown/missing0 (0.0)1170 (23.2)0 (0.0)606 (24.4)
Parity
 Primipara69 993 (32.4)1427 (28.3)34 462 (30.9)654 (26.3)
 Multipara131 994 (61.1)2274 (45.1)70 261 (63.0)1139 (45.8)
 Grand multipara9721 (4.5)247 (4.9)5911 (5.3)142 (5.7)
 Unknown/missing4322 (2.0)1095 (21.7)892 (0.8)551 (22.2)
Birth method
 Normal vaginal171 096 (79.2)N/A86 433 (77.5)N/A
 Assisted vaginal1512 (0.7)N/A1004 (0.9)N/A
 C-section39 533 (18.3)N/A22 305 (20.0)N/A
 Unknown/missing3889 (1.8)N/A1784 (1.6)N/A
Maternal age (years)
 <1818 147 (8.4)449 (8.9)8253 (7.4)167 (6.7)
 18–1923 115 (10.7)373 (7.4)11 041 (9.9)191 (7.7)
 20–34150 789 (69.8)3671 (72.8)79 072 (70.9)1832 (73.7)
 35+23 979 (11.1)550 (10.9)13 160 (11.8)296 (11.9)
HIV
 Positive71 290 (33)1372 (27.2)36 357 (32.6)659 (26.5)
 Negative142 148 (65.8)2395 (47.5)74 611 (66.9)1181 (47.5)
 Unknown/missing2592 (1.2)1276 (25.3)558 (0.5)646 (26)
  • N/A, not available.